FDA Oversight of PET Drug Products -- Questions and Answers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 3, 2012
April 10, 2019
3e894e01-dc7a-4e5e-a828-a0b032a0404f
Related Documents
ANDAs: Stability Testing of Drug Substances and Products, Questions and Answers
Guidance DocumentMay 15, 2014Center for Drug Evaluation and Research
Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs
Guidance DocumentDecember 3, 2012Center for Drug Evaluation and Research
PET Drug Products - Current Good Manufacturing Practice (CGMP)
Guidance DocumentDecember 10, 2009Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox